Association between Systemic Lupus Erythematosus and Refractory Ulcerative Colitis: What are our Therapeutic Options?

Article ID

PU2V8

In-depth study on lupus association, therapeutic options, and clinical insights for clinicians.

Association between Systemic Lupus Erythematosus and Refractory Ulcerative Colitis: What are our Therapeutic Options?

Yassine Chait
Yassine Chait
Nacir Oussama
Nacir Oussama
Ait Errami Adil
Ait Errami Adil
Samlani Zouhour
Samlani Zouhour
Krati Khadija
Krati Khadija
Oubaha Sofia
Oubaha Sofia
DOI

Abstract

Systemic lupus erythematosus (SLE)is an autoimmune disease in which the immune system through antibodies attacks its own tissues, and causes inflammation and tissue damage in the affected organs. It can affect the skin, brain, lungs, kidneys, and blood vessels (1). Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine, also called the colon, and rectum. This article is about a patient followed for systemic lupus, presenting digest if symptoms reveling ulcerative colitis, the therapeutic challenge we faced is the potential aggravation of lupus symptoms under anti TNF therapy. The patient underwent curative surgery without major complication.

Association between Systemic Lupus Erythematosus and Refractory Ulcerative Colitis: What are our Therapeutic Options?

Systemic lupus erythematosus (SLE)is an autoimmune disease in which the immune system through antibodies attacks its own tissues, and causes inflammation and tissue damage in the affected organs. It can affect the skin, brain, lungs, kidneys, and blood vessels (1). Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine, also called the colon, and rectum. This article is about a patient followed for systemic lupus, presenting digest if symptoms reveling ulcerative colitis, the therapeutic challenge we faced is the potential aggravation of lupus symptoms under anti TNF therapy. The patient underwent curative surgery without major complication.

Yassine Chait
Yassine Chait
Nacir Oussama
Nacir Oussama
Ait Errami Adil
Ait Errami Adil
Samlani Zouhour
Samlani Zouhour
Krati Khadija
Krati Khadija
Oubaha Sofia
Oubaha Sofia

No Figures found in article.

Yassine Chait. 2026. “. Global Journal of Medical Research – K: Interdisciplinary GJMR-K Volume 23 (GJMR Volume 23 Issue K3): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Classification
GJMR-K Classification: NLMC Code: WI 360
Keywords
Article Matrices
Total Views: 1272
Total Downloads: 18
2026 Trends
Research Identity (RIN)
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Association between Systemic Lupus Erythematosus and Refractory Ulcerative Colitis: What are our Therapeutic Options?

Yassine Chait
Yassine Chait
Nacir Oussama
Nacir Oussama
Ait Errami Adil
Ait Errami Adil
Samlani Zouhour
Samlani Zouhour
Krati Khadija
Krati Khadija
Oubaha Sofia
Oubaha Sofia

Research Journals